RNA-Associated Chromatin DNA-DNA Interaction Method
April 30th, 2026
808 views
Here, we present a protocol to capture RNA-associated chromatin DNA-DNA interactions for mapping RNA-related three-dimensional genome organization.
Overview
The RNA-Associated Chromatin DNA-DNA Interaction Method (RDD) is a targeted approach for mapping chromatin interactions anchored by specific RNAs. This technique enables simultaneous identification of genomic loci associated with a target RNA and the resolution of long-range DNA-DNA contacts among these loci, providing insights into spatial genome organization and regulatory mechanisms.
Key Study Components
Area of Science
- Genomics
- Epigenetics
- Molecular Biology
Background
- Chromatin interactions play a crucial role in gene regulation and genome architecture.
- RNAs, including coding and non-coding types, can organize chromatin and influence gene expression.
- Existing methods often lack the ability to map chromatin interactions specifically anchored by RNAs.
- Understanding RNA-mediated chromatin organization is essential for dissecting regulatory networks.
Purpose of Study
- To develop a robust method for mapping chromatin interactions anchored by specific RNAs.
- To enable high-resolution identification of RNA-associated genomic loci and their spatial contacts.
- To facilitate the study of enhancer-promoter pairing and long-range gene regulation mediated by RNAs.
Methods Used
- Use of biotinylated antisense probes complementary to the target RNA for enrichment of RNA-chromatin complexes.
- Cell crosslinking, chromatin fragmentation, and end-repair.
- Proximity ligation using a designed linker to join spatially adjacent DNA fragments within captured complexes.
- Purification of ligation products, sequencing library preparation, and high-throughput sequencing.
- Bioinformatic analysis to generate RNA-anchored chromatin interaction maps.
Main Results
- RDD enables locus-specific, high-resolution mapping of chromatin contacts anchored by RNAs.
- The method is applicable to both endogenous and exogenous RNAs, including those from viruses and microorganisms.
- RDD is compatible with diverse cell types and experimental conditions.
- The workflow is robust and reproducible, yielding detailed contact profiles for regulatory studies.
Conclusions
- RDD provides a powerful tool for dissecting the three-dimensional genome architecture associated with regulatory RNAs.
- The method advances understanding of how RNAs organize chromatin and regulate gene expression.
- RDD is broadly applicable for studying enhancer-promoter interactions and long-range genomic regulation.
Frequently Asked Questions
What is the main advantage of the RDD method?
RDD allows targeted mapping of chromatin interactions specifically anchored by a chosen RNA, providing high-resolution insights into RNA-mediated genome organization.
Can RDD be used with non-coding RNAs?
Yes, RDD is suitable for both coding and non-coding RNAs, enabling the study of their roles in chromatin organization and gene regulation.
Is RDD compatible with different cell types?
RDD is compatible with a wide range of cell types and experimental conditions, making it versatile for various research applications.
How does RDD enrich for RNA-chromatin complexes?
RDD uses biotinylated antisense probes complementary to the target RNA to specifically enrich RNA-chromatin complexes before proximity ligation and sequencing.
What types of RNAs can be studied using RDD?
RDD can be applied to endogenous RNAs as well as exogenous RNAs from host-infecting microorganisms and viruses.
What are the main applications of RDD?
RDD is used to study enhancer-promoter pairing, long-range gene regulation, and three-dimensional genome architecture associated with regulatory RNAs.
Executive Industry Relevance
The RNA-Associated Chromatin DNA-DNA Interaction Method (RDD) enables biopharma R&D teams to map chromatin interactions anchored by specific RNAs, providing high-resolution insight into regulatory genome architecture. This capability supports mechanistic de-risking and target validation at early discovery and preclinical inflection points, especially for RNA-mediated regulatory pathways. RDD's compatibility with diverse cell types and both endogenous and exogenous RNAs enhances its portfolio relevance for complex disease models and host-pathogen studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of RNA-mediated regulatory mechanisms and spatial genome organization.
- Supports functional target validation by mapping RNA-associated chromatin contacts.
- Facilitates mechanistic de-risking for RNA and chromatin-modifying targets.
- Provides locus-specific data to inform predictive confidence in target selection.
Screening & Assay Development
- Prepares validated chromatin interaction maps for downstream screening workflows.
- Delivers reproducible, quantitative contact profiles for assay standardization.
- Enables platform reuse across coding and non-coding RNA targets.
- Supports reliable evaluation of compounds affecting RNA-chromatin interactions.
Translational & Preclinical Research
- Aligns with disease-relevant systems by mapping regulatory RNA interactions in diverse cell types.
- Provides continuity from discovery through preclinical validation of RNA-mediated pathways.
- Enables risk-adjusted advancement decisions for RNA-targeted therapeutics.
- Supports biomarker identification through high-resolution chromatin contact profiling.
Pipeline & Workflow Integration
RDD integrates into the discovery continuum from early mechanistic studies to preclinical model validation, supporting both target identification and translational research.
- Discovery Biology: Reveals RNA-anchored chromatin interactions to clarify regulatory pathways and de-risk biological hypotheses.
- Screening: Provides quantitative, reproducible contact maps for assay development and compound screening.
- Analytics: Generates high-resolution sequencing data for comparative analysis of chromatin contacts across conditions.
- Translational Research: Enables mapping of disease-relevant RNA interactions in primary or model systems.
- Enterprise Reuse: Offers a robust, adaptable workflow for diverse RNA and chromatin research applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in RNA-mediated regulation.
- Operational Value: Delivers standardized, scalable, and reproducible chromatin interaction mapping.
- Strategic Value: Improves go/no-go decisions and capital efficiency by clarifying regulatory mechanisms early.
- Portfolio Impact: Supports risk-adjusted prioritization of RNA and chromatin-modifying targets.
Implementation Considerations
- Requires expertise in chromatin biology, RNA biochemistry, and next-generation sequencing.
- Needs access to high-throughput sequencing and bioinformatics infrastructure.
- Demands cross-team standardization for probe design and data analysis.
- Adaptable to various cell types and experimental conditions with protocol optimization.
- Dependent on probe specificity and sequencing depth for resolution and reproducibility.
Biopharma FAQs
Why does null hypothesis testing matter for RDD-based target validation?
Null hypothesis testing ensures that observed RNA-anchored chromatin interactions are statistically significant and not due to random proximity, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit the RDD discovery pipeline?
Isolating the RNA of interest using biotinylated antisense probes allows precise attribution of chromatin contacts to specific RNAs, enabling mechanistic studies and confident hypothesis testing within the discovery pipeline.
What do quantitative dependent variable measurements enable in RDD?
Quantitative sequencing readouts from RDD provide high-resolution contact profiles, enabling comparative analysis of chromatin interactions across conditions and supporting data-driven decision-making in target prioritization.
Why are replication requirements critical for RDD cross-functional collaboration?
Replication ensures reproducibility of RNA-chromatin interaction maps, facilitating cross-team data integration and supporting collaborative validation of regulatory mechanisms across discovery and translational groups.
Which statistical analysis capabilities are required before RDD implementation?
Robust statistical tools are needed to analyze sequencing data, assess interaction significance, and control for background noise, ensuring reliable interpretation and actionable insights for R&D teams.
Chapters in this video
0:00
Introduction
0:25
Chromatin Fragmentation and Preclearing with Streptavidin C1 Beads
1:51
Chromatin-RNA Probe Hybridization and Immobilization on Streptavidin C1 Beads
3:42
On-Bead Chromatin End-Repair and A-Tailing
4:59
Chromatin Proximity Ligation and Release from the Streptavidin C1 Beads
6:22
Tn5 Tagmentation of Proximity-Ligated DNA
7:19
Immobilization and PCR Amplification of Ligated DNA on M280 Beads
8:23
Results
10:18
Conclusion
